[Significance of somatic mutations on the prognosis of myelodysplastic syndromes].

doi:10.11406/rinketsu.59.1078

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

[Significance of somatic mutations on the prognosis of myelodysplastic syndromes].

[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2000

Yoshizato Tetsuichi

Abstract excerpt

During the past decade, substantial advances have been made in our understanding of the genetic basis of myelodysplastic syndromes (MDS), wherein a spectrum of major mutational targets associated with MDS, such as splicing factors and epigenetic regulators, has been revealed. The impact of mutations in these genes on disease subtypes and prognosis has also been evaluated. A mutation in SF3B1, one of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Myelodysplastic Syndromes
Share to Phosphoproteins
Share to Prognosis
Share to RNA Splicing Factors
Share to Tumor Suppressor Protein p53

Source

Open in PubMed

Identifiers

PMID: 30185709
DOI: 10.11406/rinketsu.59.1078

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics